Search

Your search keyword '"Satoko Arai"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Satoko Arai" Remove constraint Author: "Satoko Arai" Topic humans Remove constraint Topic: humans
40 results on '"Satoko Arai"'

Search Results

1. Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study

2. [A Survey on the Concomitant Use of Drugs with Enzalutamide in Medical Practice-The Effects and Resultant Decrease in Efficacy]

3. Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy

4. Young gastric cancer patient with high CA19-9 complicated by Trousseau syndrome

5. AIM/CD5L attenuates DAMPs in the injured brain and thereby ameliorates ischemic stroke

6. A scavenging system against internal pathogens promoted by the circulating protein apoptosis inhibitor of macrophage (AIM)

7. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis

8. AIM associated with the IgM pentamer: attackers on stand-by at aircraft carrier

9. Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice

10. Anti-TIF1-γ antibody and cancer-associated myositis

11. Intensive immunosuppressive therapy for endogenous lipoid pneumonia associated with rheumatoid arthritis

12. Clinical features of organizing pneumonia associated with rheumatoid arthritis

13. Association of apoptosis inhibitor of macrophage (AIM) expression with urinary protein and kidney dysfunction

14. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice

15. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma

16. Obesity-Associated Autoantibody Production Requires AIM to Retain the Immunoglobulin M Immune Complex on Follicular Dendritic Cells

17. A proteolytic modification of AIM promotes its renal excretion

18. Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim–sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseases

19. Systemic sclerosis complicated by arrhythmogenic right ventricular dysplasia that was misinterpreted as pulmonary arterial hypertension

20. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus

21. Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration

22. Stabilization and Augmentation of Circulating AIM in Mice by Synthesized IgM-Fc

23. The macrophage soluble receptor AIM/Api6/CD5L displays a broad pathogen recognition spectrum and is involved in early response to microbial aggression

24. MafB promotes atherosclerosis by inhibiting foam-cell apoptosis

25. Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans

26. [Latest topics on macrophage-derived AIM -multiple AIM roles in obesity-associated diseases-]

27. Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory diseases

29. PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression

30. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis

31. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis

32. Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patients

33. AIMing at metabolic syndrome. -Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM)

34. Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseases

35. Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus

36. [Two-year results following photodynamic therapy for age-related macular degeneration]

37. [Case of minocycline-induced pneumonitis with bilateral pleural effusion]

38. Apoptosis inhibitor of macrophage (AIM) expression in alveolar macrophages in COPD

39. Circulating AIM Prevents Hepatocellular Carcinoma through Complement Activation

40. Modification of N-glycosylation modulates the secretion and lipolytic function of apoptosis inhibitor of macrophage (AIM)

Catalog

Books, media, physical & digital resources